Cytokinetics Inc (CYTK) Financials

$73.87

$-1.48 (-1.96%)

As on 09-Sep-2026 15:37EDT

Market cap

$10,110 Mln

Revenue (TTM)

$71 Mln

P/E Ratio

--

P/B Ratio

60.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	70.96	88.04	18.47	7.53	94.59	70.43
Cost of Revenue	10.66	10.13	339.41	330.12	240.81	159.94
Gross Profit	60.30	77.91	-320.93	-322.59	-146.23	-89.51
Operating Expenses	764.92	690.17	215.31	173.61	177.98	96.80
Operating Profit (EBIT)	-704.62	-612.26	-536.25	-496.21	-324.20	-186.31
Other Income	--	--	--	--	11.34	0.33
Profit before Tax	-894.00	-784.96	-589.53	-526.24	-388.96	-215.31
Provision for Tax	--	--	--	11.72	13.60	27.06
Profit after Tax (Net Income)	-894.00	-784.96	-589.53	-526.24	-388.96	-215.31
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-388.96	-215.31

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-173.49	-659.63	-135.37	-386.32	-107.90	243.86
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1,916.61	1,881.71	1,357.37	1,107.96	1,038.06	525.60
Current Liabilities	181.43	202.45	179.67	102.68	84.62	71.86
Total Liabilities	2,105.98	1,424.54	1,401.67	824.32	1,014.78	841.32

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	716.06	507.56	293.73	196.27	219.59	305.65
Current Assets	1,208.49	916.98	1,107.94	628.05	795.19	535.67
Total Assets	2,105.98	1,424.54	1,401.67	824.32	1,014.78	841.32
Total Debt*	1,270.56	1,284.24	788.68	755.77	750.30	269.93
Net Current Assets	1,027.06	714.52	928.27	525.37	710.57	463.81

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-510.01	-395.89	-414.33	-299.52	-142.52
Cash Flow from Investing Activities	--	16.67	-553.10	239.25	-262.13	-147.78
Cash from Financing Activities	--	524.46	930.61	221.32	516.17	319.98
Net Cash Inflow / Outflow	--	--	--	--	-45.48	29.68

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-7.22	-6.41	-4.99	-5.31	-4.11	-2.56
Cash EPS ($)	--	-6.33	-4.91	-5.24	-4.05	-2.53
Adjusted Book Value ($)	--	--	--	--	--	2.90
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.17	-3.35	-4.18	-3.16	-1.69
Free Cash Flow per Share ($)	--	-4.37	-3.39	-4.20	-3.28	-2.28

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-122.85	-115.28	-104.02	-67.28	-56.21
ROE (%)	--	197.47	226.00	212.96	-572.15	-120.54
ROA (%)	-51.64	-55.55	-52.97	-57.23	-41.91	-31.32
EBIT Margin (%)	-1,175.80	-891.60	-2,722.82	-6,222.79	-357.13	-264.07
Net Margin (%)	-1,259.87	-891.60	-3,191.11	-6,988.63	-367.18	-304.29
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-17.24	3.77	1.45	-0.92	0.34	0.26
EBIT Growth (%)	-62.26	-56.05	-7.35	-38.71	-81.63	-109.88
Net Profit Growth (%)	-47.45	-33.15	-12.03	-35.30	-80.65	-69.15
EPS Growth (%)	-41.03	-0.28	0.06	-0.29	-0.60	-0.42
Book Value Growth (%)	57.45	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-9.91	-9.42	-15.72	-11.15	-17.80
Price / Book Value	60.53	-11.79	-41.03	-21.41	-40.21	15.72
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-15.82	-10.55	-10.67	-18.42	-13.07	-20.59
Close Price ($)	85.19	63.54	47.04	83.49	45.82	45.58
High Price ($)	88.31	70.98	110.00	87.58	55.80	47.90
Low Price ($)	32.66	29.31	45.66	25.98	29.26	17.72
Market Cap ($ Cr)	10,109.78	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-6.45	-1.95	-5.83	-1.96	-6.95	1.11
Short term debt to equity ratio	-0.28	-0.09	-0.23	-0.07	-0.13	0.06
Current Ratio	6.66	4.53	6.17	6.12	9.40	7.45
Quick Ratio	6.66	--	--	6.23	9.40	8.18
Interest Coverage	-6.16	-7.56	-5.81	-8.13	-6.60	-6.34

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	34.43	20.18	90.13	17.04	0.16	73.58
Asset Turnover	0.04	0.06	0.02	0.01	0.10	0.10
Receivable days	--	71.39	177.28	34.68	100.33	145.83
Inventory Days	--	--	-12.85	-6.69	-39.41	-64.22
Payable days	--	770.29	22.53	26.07	35.41	33.27
Cash Conversion Cycle	--	--	141.89	1.93	25.51	48.35

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.